This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Eric M. Barach, PA
Richard M. Nowak, MD
Detroit

JAMA. 1985;253(4):510-511.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.—

Drs Bennett and Hirshman feel that our article concerning epinephrine usage in anaphylactic shock gives the erroneous impression that epinephrine is the sole therapeutic modality for use in this clinical situation. However, we clearly stated that "other modalities are crucial to a successful therapeutic outcome. Air-way patency, supplemental oxygen, establishment of an IV access for fluids and drugs, cardiac monitoring, and ancillary medications are all important but beyond the scope of this article." Furthermore, they suggest that our discussion should have included, in detail, a complete regimen for the treatment of anaphylactic shock. From a standpoint of space, this was an impossibility, and we desired to narrow our focus such that "the intent of this article was to describe safe guidelines for the use of epinephrine in systemic anaphylactic shock."¹

It is interesting that Drs Bennett and Hirshman state that in our case report "133 µg/min is . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?